Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GNBT Generex -- Ignore unavailable to you. Want to Upgrade?

To: Hawkmoon who wrote (17)	1/10/2006 7:22:40 PM
From: rrufff	Read Replies (1) \| Respond to of 310

Yahoo board is not a place for information. GNBT is nowhere near being delisted for at least a year from this point. GNBT in November announced that they had met the Nasdaq requirements by trading above $1 bid for at least 10 consecutive days. From Nasdaq.com Companies listed on NASDAQ are required to maintain a minimum closing bid price of $1.00 per share. If a company trades for 30 consecutive business days below the applicable minimum closing bid price requirement, NASDAQ will send a deficiency notice to the company, advising that it has been afforded a "compliance period" of 180 calendar days to regain compliance with the applicable requirements. Thereafter, Capital Market companies can receive an additional 180-day compliance period if they meet all initial inclusion requrements for the Capital Market, except for the bid price requirement. If a National Market company is unable to comply with the bid price requirement prior to the expiration of its 180-day compliance period, it may transfer to The NASDAQ Capital Market, so as to take advantage of the additonal compliance period offered on that market, provided it meets all requirements for initial listing on The NASDAQ Capital Market, except for the bid price requirement. If the company does not demonstrate compliance within the compliance period, it will be issued a delisting letter, which it may appeat at that time. See Hearings Process for additional information.